 |
||
| � | ||
�� About Us
� |
|
� |
|
Biolase
Technologies, Inc.� Biolase Technology, Inc. developed and patented a revolutionary technology that allows water, a biological element, energized by a combination of lasers at the specific 2780 nm wavelength ("YSGG Laser HydroPhotonics"), to cut human tissue in a microsurgical mode. Such tissue can either be hard (teeth or bone) or soft (gum or skin) and includes enamel, the strongest of all human tissues. The company has also developed and patented the most sophisticated line of Diode Laser products and has just released the first truly portable, battery operated and affordable iLase� for the dental industry. Biolase just recently announced an initial $9 million dollar order for the product from Henry Schein Dental, a $7 billion company and the world's largest dental distributor. � |
||
|
WebSafety,
Inc. WebSafety, Inc. has developed the most comprehensive system to monitor and protect children on the Internet and cell phones available today. The company offers this crucial security system to families on an affordable subscription model, delivering recurring revenue to the top line. The combination of a recurring revenue subscription model with a company that enjoys traditional software margins presents a compelling value proposition and in our opinion, a substantial early phase investment opportunity. |
||
|
� � � Health
Discovery Corporation Personalized
medicine is becoming increasingly prevalent in the medical industry.
The realization of personalized medicine will be accomplished, in
part, with the development of molecular diagnostic tests. This
development is possible through advanced mathematical pattern
recognition techniques as demonstrated by Health Discovery
Corporation's SVM and RFE-SVM technology, shown to be effective in
hundreds of published papers from some of the top accredited
universities in the world. |
||
|
�
House of Taylor Jewelry, Inc.
� It was our honor to work with House of Taylor Jewelry on their exciting new project - building a new brand in the jewelry business. With Dame Elizabeth Taylor and Kathy Ireland as principals, there was plenty to build around. We helped the company develop a thorough executive summary and began a proactive IR campaign that drove the stock price and volume to a level in which the company was able to receive additional financing on a market cap valuation of over $160 million - at a premium to the market. |
||
|
� � Alter
NRG Corporation With Westinghouse technology, a strong balance sheet, great management and positioning in one of the hottest industries, Alter NRG had everything going for it. Management came to CMR because as a Canadian company listed on the TSX and the OTCQX (ANRGF), they needed more exposure to US investors.� We started with the company in May 2009 with the stock at $.70 and no volume on the OTCQX.� Over a six-month campaign, we saw the stock rise to a high of $2.92 and daily volume of approximately 18,000 shares on the QX.� |
||
|
�
Tasker Products, Inc. � Tasker Products was trading at $0.25 when the campaign began in May of 2003. The Company had a 4 million dollar valuation with average volume of 2,000 shares a day. The investor relations campaign started with the launch of the �World�s first breath drink,� Breath Rephresh. Capital Market Relations made an immediate impact in the market when the stock more than doubled and TKER�s average volume grew to over 50,000 shares in the first month. CMR brought in key institutional players who had initially invested $3 million into Tasker Products. Capital Market Relations was successful in helping Tasker lower its cost of capital significantly. Subsequent financing of $15 million from additional investors led to the acquisition of Pharlo Citrus Technologies, an R&D company with disruptive chemical technologies. In 2005 TKER reached a 52-week high of $4.92 with a $300 million market capitalization. Average volume had peaked to over a million shares a day. The key drivers for the investment were based on the company�s intellectual property portfolio, which is currently pending USDA approval. |
||
|
� � �
Renaissance Capital Growth & Income
Fund III � During the campaign, Chris Rosgen helped to build significant shareholder value for one of the nation�s top ranked convertible growth & income funds. RENN was trading at a 37% discount to its Net Asset Value. After launching the investor relations campaign RENN moved from a 37% discount to a 10 percent premium over its Net Asset Value. Renaissance�s Capital�s performance ranked No.1 among all convertible closed-end funds. Russell Cleveland, CEO was introduced as an expert commentator for the small cap market and he began appearing on CNBC, CNN, Bloomberg and CBS Marketwatch. The Investor Relations program led by Mr. Rosgen was so successful for Renaissance Capital that the campaign was referenced in a recent case study for �Best Practices on how to Narrow the Discount.� This private study was funded by members of the Closed-end fund industry with Thomas Herzfeld�s firm (�Mr. Closed-End Fund,�) conducting the research. Since 1998, Mr. Rosgen has personally provided investor relations services for Renaissance Capital and continues to help build shareholder value through proactive communications. |
||
|
Tri-Valley Corporation (AMEX: TIV)
The campaign began in September 2003 with Tri-Valley�s stock trading on the OTC bulletin board at $3.00. The investor relations� objectives were to help this undervalued, profitable company reach AMEX listing requirements and obtain a minimum $4.00 share price. Within the first two months, Tri-Valley stock moved up to a 52-week high of $6.82. TIV was successfully listed on the AMEX exchange. The key driver for investment was news of Tri-Valley�s potential natural gas discovery, estimated to be the second largest in California since 1948. During the campaign TIV�s average daily volume grew from under 10,000 shares daily to over 100,000 with peak volume reaching over half a million shares. TIV�s market capitalization doubled providing investors tremendous shareholder value. |
||
| � | ||
|
�Capital Market Relations 2010 |
� | |
| � | � | |
